CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 397 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93 | +60.3% | 2,041 | +97.4% | 0.03% | +50.0% |
| Q2 2023 | $58 | +20.8% | 1,034 | -2.9% | 0.02% | +12.5% |
| Q1 2023 | $48 | -67.1% | 1,065 | -70.4% | 0.02% | -72.9% |
| Q4 2022 | $146 | -100.0% | 3,598 | -85.4% | 0.06% | -91.3% |
| Q3 2022 | $1,606,000 | +1882.7% | 24,583 | +1744.2% | 0.68% | +1888.2% |
| Q2 2022 | $81,000 | -3.6% | 1,333 | 0.0% | 0.03% | +13.3% |
| Q1 2022 | $84,000 | – | 1,333 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |